Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 37,605 | 62,756 | 32,608 | 29,766 | -239,679 |
| Operating Income | -37,605 | -62,756 | -32,608 | -29,766 | 239,679 |
| Other Income | 5,391 | 4,615 | 3,662 | 2,353 | 456 |
| Pre-tax Income | -32,214 | -58,141 | -28,946 | -27,413 | 240,135 |
| Income Tax | N/A | N/A | -1,858 | -2,523 | 66,070 |
| Net Income Continuous | -32,214 | -58,141 | -27,088 | -24,890 | 174,065 |
| Minority Interests | N/A | -179 | -306 | -86 | -833 |
| Net Income | $-32,214 | $-57,962 | $-26,782 | $-24,804 | $174,898 |
| EPS Basic Total Ops | -0.82 | -1.42 | -0.63 | -0.54 | 3.90 |
| EPS Basic Continuous Ops | -0.81 | -1.43 | -0.63 | -0.55 | 3.88 |
| EPS Diluted Total Ops | -0.82 | -1.42 | -0.58 | -0.54 | 3.77 |
| EPS Diluted Continuous Ops | -0.81 | -1.43 | -0.58 | -0.55 | 3.75 |
| EBITDA(a) | $-37,524 | $-62,684 | $-32,549 | $-29,757 | $239,691 |